Corporate | 10 May 2013 10:54
|
4SC AG / Key word(s): Miscellaneous
Announcement 4SC to host conference call on 14 May 2013 to present first quarter results of 2013 Planegg-Martinsried, Germany, 10 May 2013 – 4SC AG (Frankfurt, Prime Standard: VSC), a discovery and development company of targeted small molecule drugs for cancer and autoimmune diseases, will announce first quarter results 2013 of the 4SC Group and publish the company’s report on the first three months of 2013 on 14 May 2013. On this day the Management Board of 4SC AG will host a conference call at 3pm CEST (9am EDT) to inform about the consolidated financial statements and important developments in the reporting period and beyond. Investors, financial analysts, and journalists participating in the conference call can access via the following telephone numbers:
Date: 14 May 2013
After the conference call a replay will be available in the section ‘Investors’ / ‘Events & Presentations’ / ‘Conference Calls & Webcasts’ of the website www.4sc.com . Ends About 4SC The Group managed by 4SC AG (ISIN DE0005753818) discovers and develops targeted, small-molecule drugs for treating diseases with high unmet medical needs in various autoimmune and cancer indications. These drugs are intended to provide innovative treatment options that are more tolerable and efficacious than existing therapies, and provide a better quality of life. The Company’s pipeline comprises promising products that are in various stages of clinical development. 4SC’s aim is to generate future growth and enhance its enterprise value by entering into partnerships with pharmaceutical and biotech companies. Founded in 1997, 4SC had 86 employees at 31 March 2013. 4SC AG has been listed on the Prime Standard of the Frankfurt Stock Exchange since December 2005. Legal Note This document may contain projections or estimates relating to plans and objectives relating to our future operations, products, or services; future financial results; or assumptions underlying or relating to any such statements; each of which constitutes a forward-looking statement subject to risks and uncertainties, many of which are beyond our control. Actual results could differ materially, depending on a number of factors. For more information please visit www.4sc.com or contact:
4SC AG
MC Services
The Trout Group
End of Corporate News 10.05.2013 Dissemination of a Corporate News, transmitted by DGAP – a company of EquityStory AG. The issuer is solely responsible for the content of this announcement. DGAP’s Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Media archive at www.dgap-medientreff.de and www.dgap.de |
| Language: | English | |
| Company: | 4SC AG | |
| Am Klopferspitz 19a | ||
| 82152 Martinsried | ||
| Germany | ||
| Phone: | +49 (0)89 7007 63-0 | |
| Fax: | +49 (0)89 7007 63-29 | |
| E-mail: | public@4sc.com | |
| Internet: | www.4sc.de | |
| ISIN: | DE0005753818 | |
| WKN: | 575381 | |
| Listed: | Regulierter Markt in Frankfurt (Prime Standard); Freiverkehr in Berlin, Düsseldorf, München, Stuttgart | |
| End of News | DGAP News-Service |
|
|
| 210542 10.05.2013 |